In situ mantle cell lymphoma: Clinical implications of an incidental finding with indolent clinical behavior

Haematologica

Volumn 97, Issue 2, 2012, Pages 270-278

  Carvajal Cuenca, Alejandra ^a   Sua, Luz F ^a   Silva, Nhora M ^a   Pittaluga, Stefania ^b   Royo, Cristina ^a   Song, Joo Y ^b   Sargent, Rachel L ^c   Espinet, Blanca ^d   Climent, Fina ^e   Jacobs, Samuel A ^c   Delabie, Jan ^f   Naresh, Kikkeri N ^g   Bagg, Adam ^h   Brousset, Pierre ⁱ   Warnke, Roger A ^j   Serrano, Sergi ^d   Harris, Nancy Lee ^k   Swerdlow, Steven H ^c   Jaffe, Elaine S ^b   Campo, Elías ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITÉ DE TOULOUSE   (France)

^j STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

In situ involvement by mantle cell lymphoma like cells; In situ mantle cell lymphoma; Indolent behavior

Indexed keywords

ANTINEOPLASTIC AGENT; TRANSCRIPTION FACTOR SOX11;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; MANTLE CELL LYMPHOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENTAL FINDINGS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; SOXC TRANSCRIPTION FACTORS;

EID: 84856478766     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.052621     Document Type: Article

References (33)

1. Swerdlow SH, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues fourth edition. 2008.
2. Perez-Galan P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogene-sis, and the molecular basis of treatment in the genomic era. Blood. 2011; 117(1):26-38.
3. Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101(12): 4975-81.
4. Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, et al. Outcome of deferred initial therapy in mantle-cell lym-phoma. J Clin Oncol. 2009; 27(8):1209-13.
5. Eve HE, Furtado MV, Hamon MD, Rule SA. Time to treatment does not influence overall survival in newly diagnosed mantle-cell lym-phoma. J Clin Oncol. 2009;27(32):e189-e190.
6. Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010; 70(4):1408-18.
7. Majlis A, Pugh WC, Rodriguez MA, Benedict WF, Cabanillas F. Mantle cell lym-phoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol. 1997; 15(4):1664-71.
8. Richard P, Vassallo J, Valmary S, Missoury R, Delsol G, Brousset P. In situ-like mantle cell lymphoma: a report of two cases. J Clin Pathol. 2006; 59(9):995-6.
9. Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lym-phoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003; 34(10):1030-4.
10. Espinet B, Sole F, Pedro C, Garcia M, Bellosillo B, Salido M, et al. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol. 2005; 36(11):1232-7.
11. Rodig SJ, Healey BM, Pinkus GS, Kuo FC, Dal C P, Kutok JL. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders. Cancer Genet Cytogenet. 2006;171(1): 44-51.
12. Roullet MR, Martinez D, Ma L, Fowler MH, McPhail ED, Judkins A, et al. Coexisting fol-licular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma. Am J Clin Pathol. 2010; 133(4):584-91.
13. Bassarova A, Tierens A, Lauritzsen GF, Fossa A, Delabie J. Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lym-phoma? Virchows Arch. 2008;453(4):407-11.
14. Aqel N, Barker F, Patel K, Naresh KN. In-situ mantle cell lymphoma--a report of two cases. Histopathology. 2008; 52(2):256-60.
15. Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES. In situ localization of follicular lymphoma: description and analysis by laser capture microdissec-tion. Blood. 2002; 99(9):3376-82.
16. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, et al. Follicular lym-phoma in situ: clinical implications and comparisons with partial involvement by follicu-lar lymphoma. Blood. 2011;118(11):2976-84.
17. Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood. 2008; 111(2):800-5.
18. Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, et al. The subcel-lular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol. 2008; 143(2):248-52.
19. Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lym-phoma. Haematologica. 2009;94(11):1563-8.
20. Mozos A, Royo C, Hartmann E, De JD, Baro C, Valera A, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94(11):1555-62.
21. Kuchinka BD, Kalousek DK, Lomax BL, Harrison KJ, Barrett IJ. Interphase cytogenet-ic analysis of single cell suspensions prepared from previously formalin-fixed and paraffin-embedded tissues. Mod Pathol. 1995;8(2):183-6.
22. Cook JR, Hartke M, Pettay J, Tubbs RR. Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immuno-fluorescence. J Mol Diagn. 2006;8(4):459-65.
23. Edlefsen KL, Greisman HA, Yi HS, Mantei KM, Fromm JR. Early lymph node involvement by mantle cell lymphoma limited to the germinal center: report of a case with a novel follicular in situ growth pattern. Am J Clin Pathol. 2011;136(2):276-81.
24. O'Malley D P, Vance GH, Orazi A. Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfall. Arch Pathol Lab Med. 2005;129(1):92-5.
25. Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, Gauduchon P. t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia. 2009;23(6):1190-3.
26. Roulland S, Navarro JM, Grenot P, Milili M, Agopian J, Montpellier B, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lym-phomagenesis. J Exp Med. 2006;203(11): 2425-31.
27. Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon P. Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res. 2004;64(6):2264-9.
28. Montes-Moreno S, Castro Y, Rodriguez-Pinilla SM, Garcia JF, Mollejo M, Castillo ME, et al. Intrafollicular neoplasia/in situ fol-licular lymphoma: review of a series of 13 cases. Histopathology. 2010;56(5):658-62.
29. Racke F, Simpson S, Christian B, Blum K, Hasserjian R, Zhao W. Evidence of long latency periods prior to development of mantle cell lymphoma. American Society of Hematology. 2010. [Abstract] Dec 6; San Diego, CA 2010.
30. Neto AG, Oroszi G, Protiva P, Rose M, Shafi N, Torres R. Colonic in situ mantle cell lym-phoma. Ann Diagn Pathol. 2011 Aug 11. [Epub ahead of print]
31. Christian B, Zhao W, Hamadani M, Sotomayor EM, Navarro W, Devine SM, et al. Mantle cell lymphoma 12 years after allo-geneic bone marrow transplantation occurring simultaneously in recipient and donor. J Clin Oncol. 2010;28(31):e629-e632.
32. Adam P, Katzenberger T, Eifert M, Ott MM, Rosenwald A, Muller-Hermelink HK, et al. Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol. 2005;29(12):1661-4.
33. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-32.